DGAP-News: RHÃN-KLINIKUM AG / Key word(s): Quarter
Results/Miscellaneous
RHÃN-KLINIKUM AG: Interim Report for the First Quarter: Period of
Transition - Transfer of Hospitals Sold to Fresenius / Helios -
Financial Figures Reflect Exceptional Situation
14.05.2014 / 07:00
---------------------------------------------------------------------
Corporate News
RHÃN-KLINIKUM AG Schlossplatz 1 D-97616 Bad Neustadt / Saale
www.rhoen-klinikum-ag.com
Interim Report for the First Quarter: Period of Transition - Transfer of
Hospitals Sold to Fresenius / Helios - Financial Figures Reflect
Exceptional Situation
- 567,137 patients treated
- Financial figures significantly influenced by extraordinary effects
- Revenues amount to EUR 629.5 million
- EBITDA stands at EUR 1,488.0 million due to sales proceeds
The first quarter in 2014 was a period of transition for RHÃN-KLINIKUM AG.
The company's financial figures were significantly influenced by the sale
of a total of 40 hospitals to Fresenius / Helios which was largely
completed in this period. The financial statement for the first three
months of the current financial year therefore includes two months with the
full consolidation of the previous portfolio in its entirety as well as the
month of March with an adjusted balance sheet showing the concluded sale
transaction. Added to this are numerous primarily positive one-off effects
but there are also burdens, both of which can generally be attributed to
the transaction.
The company's new, highly specialised portfolio concentrating on
cutting-edge medical care now consists of the hospitals in Bad Berka, Bad
Neustadt, Frankfurt (Oder) and the university hospitals in Giessen and
Marburg. Furthermore the hospitals in Boizenburg, Cuxhaven and
Waltershausen-Friedrichroda still currently belong to the corporate group.
We are now working on a long-term future concept for these hospitals in
order to guarantee healthcare delivery, offer security for the future and
satisfy the interests of both patients and employees. The shares in Dr.
Horst Schmidt Kliniken in Wiesbaden are to be transferred probably at the
end of May following approval by the town of Wiesbaden as the majority
shareholder. This would complete the sale transaction for all hospitals.
Taking the above exceptional situation into account, 567,137 patients were
treated in the hospitals of RHÃN-KLINIKUM AG in the first quarter of the
current financial year. Revenues are at EUR 629.5 million while earnings
before interest, taxes, depreciation and amortisation (EBITDA) amount to
EUR 1,488.0 million.
Outlook
The rest of the financial year will also be influenced by the structural
re-orientation of the company as well as other short-term consequences of
the sale transaction. Implementing the future concept for the hospitals in
Boizenburg, Cuxhaven and Waltershausen-Friedrichroda and the consolidation
of Dr. Horst Schmidt Kliniken which will continue into the second quarter
will leave a mark on the corporate financial figures.
RHÃN-KLINIKUM AG will not give a target for revenues and earnings for the
current financial year 2014 due to these additional circumstances. We
confirm our outlook with revenues of EUR 1.06 billion to EUR 1.12 billion
and earnings before interest, tax, depreciation and amortisation (EBITDA)
of between EUR 145 million and EUR 155 million for 2015, the first full
financial year with the new corporate structure. This outlook is subject to
any regulatory changes which may affect the framework conditions for
financing hospitals.
"The process of developing from a heterogeneously decentralised hospital
network into an integrated healthcare group is in full swing; the company
is growing and coming together in many ways," said the CEO, Dr. Dr. Martin
Siebert. "In the future we shall be able to focus on offering our patients
innovative, maximum-care-orientated medical services even more than in the
past. Expanding the medical care network with additional insurance which we
are currently strongly promoting with our partners will grant us an
improved competitive position and offer us attractive future growth
potential."
**************************************************************************
RHÃN-KLINIKUM AG is one of the largest healthcare providers in Germany.
With ten hospitals in five locations and a total of 5,300 beds the company
intends to expand its expertise in science-driven medical care. The
hospitals in Boizenburg, Cuxhaven and Waltershausen-Friedrichroda also
currently belong to the corporate group. A total of approx. 15,000
employees work for RHÃN-KLINIKUM AG.
Further information is available at: www.rhoen-klinikum-ag.com.
Your Contact Persons:
RHÃN-KLINIKUM AG
Achim Struchholz
Group Division Head of Corporate Communication
Schlossplatz 1
97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1327
Facsimile: + 49 - 9771 65-1820
E-Mail: kommunikation@rhoen-klinikum-ag.com
Dr. Kai G. Klinger
Head of Investor Relations
Schlossplatz 1
97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1318
Facsimile: + 49 - 9771 99-1736
E-Mail: kai.klinger@rhoen-klinikum-ag.com
End of Corporate News
---------------------------------------------------------------------
14.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: RHÃN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
268240 14.05.2014
DGAP-News: RHÃN-KLINIKUM AG: Interim Report for the First Quarter: Period of Transition - Transfer of Hospitals Sold to Fresenius / Helios - Financial Figures Reflect Exceptional Situation
| Source: EQS Group AG